299 related articles for article (PubMed ID: 9517602)
1. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice.
Sato K; Suga M; Akaike T; Fujii S; Muranaka H; Doi T; Maeda H; Ando M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):853-7. PubMed ID: 9517602
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury.
Enoki Y; Ishima Y; Tanaka R; Sato K; Kimachi K; Shirai T; Watanabe H; Chuang VT; Fujiwara Y; Takeya M; Otagiri M; Maruyama T
PLoS One; 2015; 10(6):e0130248. PubMed ID: 26086073
[TBL] [Abstract][Full Text] [Related]
3. Administration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in mice.
Sakai S; Ochiai H; Mantani N; Kogure T; Shibahara N; Terasawa K
Mediators Inflamm; 2001 Apr; 10(2):93-6. PubMed ID: 11405556
[TBL] [Abstract][Full Text] [Related]
4. Zanamivir Diminishes Lung Damage in Influenza A Virus-infected Mice by Inhibiting Nitric Oxide Production.
Zablockienė B; Kačergius T; Ambrozaitis A; Žurauskas E; Bratchikov M; Jurgauskienė L; Zablockis R; Gravenstein S
In Vivo; 2018; 32(3):473-478. PubMed ID: 29695548
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals.
Akaike T; Noguchi Y; Ijiri S; Setoguchi K; Suga M; Zheng YM; Dietzschold B; Maeda H
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2448-53. PubMed ID: 8637894
[TBL] [Abstract][Full Text] [Related]
6. Prior exposure to acrolein accelerates pulmonary inflammation in influenza A-infected mice.
Ong FH; Henry PJ; Burcham PC
Toxicol Lett; 2012 Aug; 212(3):241-51. PubMed ID: 22705057
[TBL] [Abstract][Full Text] [Related]
7. [The use of apoptosis inducers in the therapy of experimental influenza infection and preventing of chronic post-influenza lung damage].
Zarubaev VV; Tribulovich VG; Beliavskaia SV; Barlev NA; Kiselev OI
Tsitologiia; 2014; 56(3):241-7. PubMed ID: 25509421
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.
Betts RJ; Mann TS; Henry PJ
J Pharmacol Exp Ther; 2012 Dec; 343(3):725-35. PubMed ID: 22988062
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice.
Sakai S; Kawamata H; Mantani N; Kogure T; Shimada Y; Terasawa K; Sakai T; Imanishi N; Ochiai H
J Virol; 2000 Mar; 74(5):2472-6. PubMed ID: 10666283
[TBL] [Abstract][Full Text] [Related]
10. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.
Van Der Sluijs KF; Van Elden LJ; Arens R; Nijhuis M; Schuurman R; Florquin S; Kwakkel J; Akira S; Jansen HM; Lutter R; Van Der Polls T
Immunology; 2005 Jan; 114(1):112-20. PubMed ID: 15606801
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.
Huang H; Li H; Zhou P; Ju D
Cytokine; 2010 Aug; 51(2):151-7. PubMed ID: 20427198
[TBL] [Abstract][Full Text] [Related]
12. Effect of Wen-Pi-Tang extract on lung damage by influenza virus infection.
Yokozawa T; Sekiya M; Cho EJ; Kurokawa M; Shiraki K
Phytomedicine; 2004 Nov; 11(7-8):625-32. PubMed ID: 15636176
[TBL] [Abstract][Full Text] [Related]
13. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
[TBL] [Abstract][Full Text] [Related]
14. Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice.
Schouten M; de Boer JD; van der Sluijs KF; Roelofs JJ; van't Veer C; Levi M; Esmon CT; van der Poll T
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):789-94. PubMed ID: 21330465
[TBL] [Abstract][Full Text] [Related]
15. Kinetic profile of influenza virus infection in three rat strains.
Daniels MJ; Selgrade MK; Doerfler D; Gilmour MI
Comp Med; 2003 Jun; 53(3):293-8. PubMed ID: 12868575
[TBL] [Abstract][Full Text] [Related]
16. Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals.
Duan S; Gu L; Wang Y; Zheng R; Lu J; Yin J; Guli L; Ball M
Am J Chin Med; 2009; 37(6):1167-77. PubMed ID: 19938224
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of Hypericum perforatum L. extract for mice infected with an influenza A virus.
Xiuying P; Jianping L; Ruofeng S; Liye Z; Xuehong W; Yan L
Can J Physiol Pharmacol; 2012 Feb; 90(2):123-30. PubMed ID: 22260349
[TBL] [Abstract][Full Text] [Related]
18. Early regulation of viral infection reduces inflammation and rescues mx-positive mice from lethal avian influenza infection.
Song MS; Cho YH; Park SJ; Pascua PN; Baek YH; Kwon HI; Lee OJ; Kong BW; Kim H; Shin EC; Kim CJ; Choi YK
Am J Pathol; 2013 Apr; 182(4):1308-21. PubMed ID: 23395090
[TBL] [Abstract][Full Text] [Related]
19. The roots of Ilex asprella extract lessens acute respiratory distress syndrome in mice induced by influenza virus.
Dai WP; Li G; Li X; Hu QP; Liu JX; Zhang FX; Su ZR; Lai XP
J Ethnopharmacol; 2014 Sep; 155(3):1575-82. PubMed ID: 25102242
[TBL] [Abstract][Full Text] [Related]
20. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice.
Karupiah G; Chen JH; Mahalingam S; Nathan CF; MacMicking JD
J Exp Med; 1998 Oct; 188(8):1541-6. PubMed ID: 9782132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
